Athira Pharma Investors Win OK Of $10M Deal On Second Try
Over 30,000 Athira Pharma investors have scored preliminary approval of a $10 million settlement over claims its former CEO manipulated studies relating to an Alzheimer's drug, five months after a Washington...To view the full article, register now.
Already a subscriber? Click here to view full article